Latest Novo Nordisk News & Updates

See the latest news and media coverage for Novo Nordisk. We track all announcements, press releases, and industry mentions in real time, all in one place.

Novo Nordisk

Global healthcare company focused on diabetes and obesity

novonordisk.com

Headquarters: Bagsværd, Denmark
Founded year: 1923
Company type: Public company
Number of employees: 60,000+

Last updated Today

Latest news about Novo Nordisk

In short: Novo Nordisk advanced its obesity pipeline with positive CagriSema and Zenagamtide data while expanding the Wegovy pill's global market presence.

Company announcements

June 22 Novo Nordisk

Novo Nordisk updates share repurchase programme transactions

Since 15 June, the company repurchased 225,000 B shares at an average price of 286.10 DKK per share.

June 11 Novo Nordisk

Novo Nordisk reports an IT security incident with unauthorized access

The incident involved copying of non-public data, including personal data, externally. Core business operations remain unaffected.

June 11 Novo Nordisk

Novo Nordisk gets UK approval for Wegovy pill

The daily semaglutide tablets offer an alternative to injections for adults with obesity or overweight.

June 7 Novo Nordisk

Novo Nordisk announces promising trial results

Phase 3 trials showed consistent reductions in blood sugar and weight across type 2 diabetes stages.

Media coverage

Yesterday Berlingske

In 2027, one in eight Britons will take weight-loss medication after approval of Novo's slimming pill.

The Wegovy pill, which has just been approved for sale in the UK, will cause even more people to cut back on candy purchases and instead spend more money...

Yesterday Ekstra Bladet

Putin's obesity weapon: Russia steals Novo golden bird

Novo Nordisk fights with copycats, and now they are hit by a decision from Russia. A Russian court has indeed given the pharmaceutical company Promomed permission...

June 22 Yahoo

Medicare update: Millions will see GLP-1 costs plummet to $50 per month

By capping out-of-pocket costs at $50 per month, federal officials could open the door for millions...

June 22 Reuters

South Africa court bars iDexis from selling compounded Ozempic in Novo Nordisk case

South Africa's High Court has granted Novo Nordisk an ‌interim interdict barring a local pharmacy gr...

Never miss news about Novo Nordisk

Track Novo Nordisk and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Novo Nordisk competitors & trending companies

Browse news for competitors to Novo Nordisk and other trending companies.